IL7 and glioblastoma: Indeed, this research illustrated that oAD-IL7 is a potential supplementary treatment for enhancing the therapeutic effectiveness of B7H3-CAR-T in glioblastoma through establishing stimulating signals for T cells that infiltrate to tumor site [169].